These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 6203577
1. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate. Faille A, Turmel P, Charron DJ. Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577 [Abstract] [Full Text] [Related]
2. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Guy K, Meehan RR, Dewar AE, Larhammar D. Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424 [Abstract] [Full Text] [Related]
3. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line. Sairenji T, Spiro RC, Humphreys RE. Hematol Oncol; 1984 Feb; 2(4):381-9. PubMed ID: 6098544 [Abstract] [Full Text] [Related]
4. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains. Karr RW, Alber C, Goyert SM, Silver J, Duquesnoy RJ. J Exp Med; 1984 May 01; 159(5):1512-31. PubMed ID: 6425448 [Abstract] [Full Text] [Related]
5. Immunomodulation of HLA class I and II expression on a human tumor derived cell line by 5-azacytidine, bacterial lipopolysaccharide, gamma interferon and a phorbol ester. Santamaría M, Muñoz E, Molina I, Ortega C, Peña J. Methods Find Exp Clin Pharmacol; 1989 Apr 01; 11(4):269-72. PubMed ID: 2474117 [Abstract] [Full Text] [Related]
6. CD 1-8 antigens on human diphtheria toxoid T lymphocyte clones: expression and modulation by TPA, sodium butyrate, and 5-azacytidine. Triebel F, De Roquefeuil S, Bernard A, Blanc C, Debre P. Hum Immunol; 1986 Jul 01; 16(3):221-33. PubMed ID: 2424873 [Abstract] [Full Text] [Related]
7. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. Sone T, Tsukamoto K, Hirayama K, Nishimura Y, Takenouchi T, Aizawa M, Sasazuki T. J Immunol; 1985 Aug 01; 135(2):1288-98. PubMed ID: 3159789 [Abstract] [Full Text] [Related]
8. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells. Spiro RC, Sairenji T, Humphreys RE. J Immunol; 1985 May 01; 134(5):3539-49. PubMed ID: 3856614 [Abstract] [Full Text] [Related]
9. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules. Karr RW, Hsu SH, Bias WB. Hum Immunol; 1986 Feb 01; 15(2):198-210. PubMed ID: 3081469 [Abstract] [Full Text] [Related]
10. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Spits H, Borst J, Giphart M, Coligan J, Terhorst C, De Vries JE. Eur J Immunol; 1984 Apr 01; 14(4):299-304. PubMed ID: 6609821 [Abstract] [Full Text] [Related]
11. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression. Al-Katib A, Koziner B. Br J Haematol; 1984 Jul 01; 57(3):373-82. PubMed ID: 6378248 [Abstract] [Full Text] [Related]
12. Modulation of the expression of HLA class II antigens by gamma interferon and phorbol ester TPA on myeloid leukaemic cell lines. Alonso MC, Navarrete C, Solana R, Ramirez R, Peña J, Festenstein H. J Immunogenet; 1986 Jul 01; 13(2-3):255-61. PubMed ID: 3102618 [Abstract] [Full Text] [Related]
13. Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines. Wang CY, Al-Katib A, Lane CL, Koziner B, Fu SM. J Exp Med; 1983 Nov 01; 158(5):1757-62. PubMed ID: 6355364 [Abstract] [Full Text] [Related]
14. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10. Chen YX, Evans RL, Pollack MS, Lanier LL, Phillips JH, Rousso C, Warner NL, Brodsky FM. Hum Immunol; 1984 Aug 01; 10(4):221-35. PubMed ID: 6332101 [Abstract] [Full Text] [Related]
15. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells. Navarrete C, Fernandez N, Alonso MC, Festenstein H. Hum Immunol; 1986 May 01; 16(1):52-68. PubMed ID: 3519548 [Abstract] [Full Text] [Related]
16. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility. Goyert SM, Silver J. Proc Natl Acad Sci U S A; 1983 Sep 01; 80(18):5719-23. PubMed ID: 6193521 [Abstract] [Full Text] [Related]
17. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products. Puri NK, de Kretser T, Brandon MR. Hum Immunol; 1987 Nov 01; 20(3):195-207. PubMed ID: 3501780 [Abstract] [Full Text] [Related]
18. Identification of a human Ia antigen that is different from HLA-DR and DC antigens. Makgoba MW, Hildreth JE, McMichael AJ. Immunogenetics; 1983 Nov 01; 17(6):623-35. PubMed ID: 6407986 [Abstract] [Full Text] [Related]
19. HLA-DS molecules and their relation to supertypic specificities. Goyert SM, Moriuchi J, Winchester R, Silver J. Hum Immunol; 1983 Sep 01; 8(1):53-63. PubMed ID: 6195135 [Abstract] [Full Text] [Related]
20. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies. Kraïba R, Loiseau P, Faille A, Poirier O, Piatier-Tonneau D, Degos L, Abita JP, Charron D. Leukemia; 1989 May 01; 3(5):386-93. PubMed ID: 2497283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]